Weight loss pills may fight Cancer-Causing inflammation
NCT ID NCT05756764
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 30 times
Summary
This pilot study looks at how common weight loss medications change inflammatory cells and fats in the blood of 30 obese adults aged 35-60. Researchers want to see if losing weight with drugs like Wegovy or Qsymia reduces chronic inflammation linked to cancer. Participants take standard weight loss meds for 6 months, and their blood is tested before and after.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO
New Orleans, Louisiana, 70112, United States
-
Ochsner Health System - Biospecimen
New Orleans, Louisiana, 70121, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Semaglutide, Phentermine-Topiramate, Phentermine, Tirzepatide, Topiramate, Diethylpropion, Naltrexone/Bupropion
What this could lead to
If successful, this study could reveal how weight loss drugs reduce inflammation, potentially pointing toward ways to lower cancer risk in obese individuals.
What could go wrong
This is a small pilot study with only 30 participants, so results may not apply broadly. It measures markers, not actual cancer outcomes, so any link to cancer prevention is speculative.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.